Display options
Share it on

J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):181-91. doi: 10.1002/jcsm.12019. Epub 2015 Apr 30.

Gender-specific differences in the development of sarcopenia in the rodent model of the ageing high-fat rat.

Journal of cachexia, sarcopenia and muscle

Robert Kob, Claudia Fellner, Thomas Bertsch, Astrid Wittmann, Daria Mishura, Cornel C Sieber, Barbara E Fischer, Christian Stroszczynski, Cornelius L Bollheimer

Affiliations

  1. Institute for Biomedicine of Aging, Friedrich-Alexander-Universität Erlangen-Nürnberg, Nuremberg, Germany.
  2. Institute of Radiology, University Hospital Regensburg, Regensburg, Germany.
  3. Institute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Paracelsus Medical University, Nuremberg, Germany.
  4. Department of General Internal Medicine and Geriatrics, Hospital of the Order of St. John of God, Regensburg, Germany.

PMID: 26136194 PMCID: PMC4458084 DOI: 10.1002/jcsm.12019

Abstract

BACKGROUND: Sarcopenia is linked to functional impairments, loss of independence, and mortality. In the past few years, obesity has been established as being a risk factor for a decline in muscle mass and function. There are several molecular pathological mechanisms, which have been under discussion that might explain this relationship. However, most studies were conducted using male animals and for a short period of time.

METHODS: In this study, the gender-specific effect of long-term, high-fat content feeding in Sprague-Dawley rats was examined. Development of the quadriceps muscle of the animals was monitored in vivo using magnetic resonance. The results of these measurements and of the biochemical analysis of the aged muscle were compared.

RESULTS: Surprisingly, only male but not female rats showed a decline in muscle cross-sectional area at 16 months of age as a result of a chronic oversupply of dietary fats. This loss of muscle mass could not be explained by either de-regulation of the anabolic Akt pathway or by up-regulation of the main ubiquitin ligases of muscle, MAFbx and MuRF-1. However, fusion of satellite cells to myotubes was induced by the high-fat diet in male rats, possibly as a result of an increased need for compensatory regeneration processes. Caspase-3-dependent apoptosis induction, irrespective of diet, seems to be the major determinant of muscle decline during ageing in male but not female rats.

CONCLUSION: Taken together, activation of the apoptosis-inducing Caspase-3 seems to be the most important trigger for the age-related muscle loss. Male rats were more prone to the decline of muscle during ageing than female animals, which was further enforced by a long-term, high fat diet.

© 2015 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society of Sarcopenia, Cachexia and Wasting Disorders.

Keywords: Ageing skeletal muscle; Gender‐specificity; Lipotoxicity; Metabolism; Sarcopenic obesity

References

  1. Acta Physiol (Oxf). 2009 Oct;197(2):151-9 - PubMed
  2. Biogerontology. 2014 Jun;15(3):217-32 - PubMed
  3. Sports Med. 2005;35(6):473-83 - PubMed
  4. J Appl Physiol (1985). 2005 Jan;98(1):315-21 - PubMed
  5. Cell Physiol Biochem. 2008;22(5-6):539-48 - PubMed
  6. Mech Ageing Dev. 2006 Oct;127(10 ):794-801 - PubMed
  7. Mayo Clin Proc. 2010 Nov;85(11):991-1001 - PubMed
  8. Age Ageing. 2000 May;29(3):235-42 - PubMed
  9. Mol Biol Cell. 2007 Apr;18(4):1397-409 - PubMed
  10. Gerontology. 2011;57(1):66-75 - PubMed
  11. Obes Res. 2004 Dec;12(12):1995-2004 - PubMed
  12. Geriatr Gerontol Int. 2014 Feb;14 Suppl 1:8-14 - PubMed
  13. J Gerontol. 1990 May;45(3):M82-8 - PubMed
  14. J Clin Invest. 1998 Jan 1;101(1):74-8 - PubMed
  15. J Physiol. 2009 Apr 1;587(Pt 7):1593-605 - PubMed
  16. Gerontology. 2014;60(6):530-8 - PubMed
  17. Am J Med. 2006 Jun;119(6):526.e9-17 - PubMed
  18. Age Ageing. 2010 Jul;39(4):412-23 - PubMed
  19. Age (Dordr). 2012 Jun;34(3):669-79 - PubMed
  20. PLoS One. 2009;4(3):e4973 - PubMed
  21. Physiol Behav. 2008 May 23;94(2):231-41 - PubMed
  22. Int J Endocrinol. 2013;2013:204164 - PubMed
  23. J Appl Physiol (1985). 2007 Mar;102(3):919-25 - PubMed
  24. Obesity (Silver Spring). 2009 Nov;17(11):2082-8 - PubMed
  25. Ann N Y Acad Sci. 2000 May;904:437-48 - PubMed
  26. Wien Med Wochenschr. 2011 Sep;161(17-18):409-15 - PubMed
  27. Nutrition. 2012 Jun;28(6):616-22 - PubMed
  28. FASEB J. 2013 Oct;27(10):3905-16 - PubMed
  29. Int J Obes Relat Metab Disord. 2001 Sep;25(9):1316-21 - PubMed
  30. Clin Nutr. 2014 Oct;33(5):737-48 - PubMed
  31. Am J Clin Nutr. 2010 Oct;92(4):826-34 - PubMed
  32. Aging Cell. 2014 Feb;13(1):92-101 - PubMed
  33. Biogerontology. 2012 Dec;13(6):609-20 - PubMed
  34. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1341-50 - PubMed
  35. Am J Physiol Endocrinol Metab. 2012 Jul 1;303(1):E31-9 - PubMed
  36. Scand J Med Sci Sports. 2010 Feb;20(1):39-48 - PubMed
  37. Can Med Assoc J. 1964 Mar 21;90:723-5 - PubMed
  38. Horm Behav. 2014 Jun;66(1):95-103 - PubMed
  39. Exp Gerontol. 2002 Jun;37(6):757-67 - PubMed
  40. Biochem J. 2012 Jan 1;441(1):1-21 - PubMed
  41. Mech Ageing Dev. 2009 Apr;130(4):272-80 - PubMed
  42. Biochem Cell Biol. 2012 Apr;90(2):164-72 - PubMed
  43. Curr Pharm Des. 2010;16(8):906-14 - PubMed
  44. J Am Geriatr Soc. 2013 Jun;61(6):974-80 - PubMed
  45. Am J Clin Nutr. 2009 Jun;89(6):1895-900 - PubMed
  46. J Clin Endocrinol Metab. 2001 Dec;86(12):5755-61 - PubMed
  47. Apoptosis. 2009 Dec;14(12):1484-95 - PubMed
  48. Pflugers Arch. 2005 Sep;450(6):437-46 - PubMed
  49. J Cell Biol. 2009 Jun 15;185(6):1083-95 - PubMed
  50. Exp Physiol. 2011 Feb;96(2):179-93 - PubMed
  51. Maturitas. 2013 Sep;76(1):88-94 - PubMed

Publication Types